Ro.co vs He & She MD: Oral Wegovy vs Bundled Coaching Plans
Quick verdict: For injection-averse patients who prioritize an FDA-approved oral option, Ro.co stands out with access to the Wegovy pill and a $39 get-started option. For patients who want bundled coaching, 1:1 clinician messaging and progress tracking with compounded medication options, He & She MD is the stronger fit.
Ro.co vs He & She MD at a glance
This comparison focuses on the most distinctive differences supported by the source: medication type and regulatory status, entry pricing and price structure, bundled support and coaching, shipping and program terms, and clinician review and eligibility.
Direct comparison table
| Criteria | Ro.co | He & She MD |
|---|---|---|
| Medications offered | Access to the Wegovy pill, FDA-approved oral GLP-1; also prescribes FDA-approved finished meds when appropriate | Compounded semaglutide injections, oral semaglutide, tirzepatide injections (produced in USP-compliant, state-regulated pharmacies) |
| Regulatory note | FDA-approved finished medication; compounded meds, when offered, are not FDA-approved | Compounded medications are not reviewed by the FDA for safety, effectiveness or quality |
| Starting price | Get started online for just $39 | Semaglutide injections start at $139/mo (intro six-month rate) |
| Support included | Standard telehealth clinician review; pricing disclosed before consultation | Coaching app with 1:1 clinician messaging, GLP-1 coaching and progress tracking included at no extra cost |
| Shipping and fees | Not verified on the captured page | Free expedited shipping, no membership fee; promo rates are six-month intro offers that renew higher |
1. Medication type and regulatory status
Ro.co is unique in this comparison as the only mainstream platform here offering the Wegovy pill, the first and only FDA-approved oral GLP-1 weight loss medication. That means Ro can prescribe an FDA-approved finished product rather than a compounded injectable for patients who are injection-averse. He & She MD sells compounded GLP-1s produced in USP-compliant, state-regulated pharmacies, and the source explicitly notes those compounded medications are not reviewed by the FDA for safety, effectiveness or quality.
See He & She MD plans from $139/mo
2. Pricing: entry cost versus bundled terms
Ro.co promotes a low get-started online price of $39. The source emphasizes this is an entry point and that ongoing branded medication pricing varies and can be high depending on the plan. He & She MD advertises introductory six-month rates such as semaglutide injections starting at $139/month and oral semaglutide or tirzepatide at $199/month; those are six-month intro prices that renew higher after the initial term. The captured evidence warns readers to budget for the renewal price rather than the temporary promo rate.
3. Support and coaching
He & She MD bundles a coaching app with every plan, including 1:1 clinician messaging, GLP-1-specific coaching, and progress tracking at no extra cost. The source positions He & She MD for patients who stalled on minimal subscriptions and want built-in accountability. Ro.co is described as an established, full-service telehealth platform that prescribes FDA-approved medications after clinician review, but the captured evidence does not present a bundled coaching app equivalent to He & She MD.
4. Shipping, fees and program structure
He & She MD includes free expedited shipping and no membership fee per the source, while promotional pricing applies to initial six-month terms that renew at a higher rate. For Ro.co the captured page did not verify shipping, fees, membership, or cancellation policy; the source only states Ro discloses pricing before you complete your consultation and that there are no hidden fees.
5. Clinician review and eligibility
Ro.co specifies treatment is available only when a licensed clinician determines it is medically appropriate. He & She MD also requires consultation and prescription by a clinician through its platform and notes not all customers will qualify for a prescription. Both providers therefore rely on clinician review and eligibility determinations.
How to choose: final guidance on Ro.co vs He & She MD
Choose Ro.co if you want access to an FDA-approved oral GLP-1 option and a $39 online get-started entry point. Ro.co is the only mainstream option here with the Wegovy pill and emphasizes FDA-approved finished medications and pricing disclosure before consultation.
Choose He & She MD if you prefer a program that bundles coaching, 1:1 clinician messaging and progress tracking with compounded GLP-1 medication options and free expedited shipping, but be prepared for six-month promotional pricing that renews higher.
Try He & She MD coaching plans
Both platforms require clinician review and have different trade offs: Ro.co for FDA-approved oral medication and brand certainty; He & She MD for bundled coaching and lower introductory compound pricing. Use this comparison of Ro.co vs He & She MD to match the program features and regulatory preferences that matter most to you.